MATTES GLENN R. (President and CEO) sold 80.0% of their position (40K shares) of TFF PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $672.8K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 2/18/2021ACC: 0001213900-21-010415
DirectorOfficer· President and CEO
Since Oct 2019
-40K
Net shares
Net seller
$672.8K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
40K acquired · 80K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+40K
Price / share
$2.50
Trade value
$100K
% of position
400.0%
2/16/2021
10K→50K
Common Stock
Direct
Shares
−40K
Price / share
$16.82
Trade value
$672.80K
% of position
80.0%
2/16/2021
50K→10K
Total
Net shares
+0.00
Net value
-$572.80K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/16/2021 | M · Option Exercise | +40K | $2.50 | $100K | 400.0% | 10K | 50K |
| Common Stock Direct | 2/16/2021 | S · Sale | −40K | $16.82 | $672.80K | 80.0% | 50K | 10K |
| Total | +0.00 | -$572.80K | ||||||
Derivative Transactions1
Stock Options (Right to Buy)
Direct
Converts to
Common Stock
40K shares
Shares
−40K
Strike price
2.5
Held after
994.23K
Exercisable
—
2/16/2021
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Options (Right to Buy) Direct | Common Stock40K shares | 2/16/2021 | M · Option Exercise | −40K | 2.5 | — | 994.23K |